| Financial Year |
March 31 2023 |
| Monetary Funds |
230,879,362.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
200,577,374.92 |
| Advances to Suppliers |
30,925,732.90 |
| Other Receivables |
52,257,139.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
109,375.00 |
| Dividend Receivable |
-- |
| Inventories |
277,579,472.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
15,340,877.90 |
| Other Current Assets |
73,459,010.59 |
| Total Current Assets |
915,223,052.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
35,701,821.01 |
| Long-term Equity Investment |
178,826,190.03 |
| Investment Properties |
-- |
| Fixed Assetes |
412,651,997.46 |
| Under-construction Projects |
1,001,344,401.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
480,869,231.15 |
| R&D expenses |
125,067,870.80 |
| Goodwill |
298,271,825.21 |
| Long-Term Deferred and Prepaid Expenses |
18,917,250.72 |
| Deferred Income Tax Assets |
115,546,083.71 |
| Other Non-Current Assets |
708,059,550.57 |
| Sub-Total of Non-Current Assets |
3,584,292,257.75 |
| Total Assets |
4,499,515,310.13 |
| Short-Term Loans |
88,209,363.62 |
| Trading Financial liabilities |
-- |
| Notes Payable |
70,000.00 |
| Accounts Payable |
553,737,378.06 |
| Accounts Received In Advance |
157,800.75 |
| Employee Compensation Payable |
31,307,738.23 |
| Taxes Payable |
23,601,626.42 |
| Interest Payable |
20,954,430.41 |
| Dividend Payable |
9,148,310.86 |
| Other payables |
871,554,429.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
370,908,289.60 |
| Other Current Liabilities |
20,617,432.76 |
| Sub-Total of Current Liabilities |
2,134,758,290.89 |
| Long-term Loans |
580,782,500.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
182,432,250.13 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,429,618.92 |
| Deferred Income Tax Liabilities |
20,438,483.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
878,211,647.49 |
| Total Liabilities |
3,012,969,938.38 |
| Paid-In Capital(Or Share Stock) |
1,147,094,532.00 |
| Capital Surplus |
1,480,679,714.57 |
| Surplus Reserve |
40,790,254.99 |
| LESS:Treasury Stock |
142,906,016.00 |
| Undistributed Profits |
-1,737,418,372.89 |
| Minority Stockholder's Interest |
727,391,224.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
759,154,147.69 |
| Owner's Equity（Stockholder's Equity） |
1,486,545,371.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,499,515,310.13 |
